Return
Novel mechanisms linking platelet activation to antiphospholipid syndrome
M
E
P
P
DOI:10.1016/j.coi.2026.102791.png)
Abstract
En 中文
• Increased evidence supports the persistent platelet activation in APS. • APS platelets display not only proadhesive but also procoagulant (TFpos) phenotype. • Increase of TFpos-platelet-leukocyte aggregates is a marker of platelet activation. • TFpos-platelet/TFpos-platelet -leukocyte aggregates may increase the thrombotic risk. • The two-hit APS model should evolve into a multi-hit model.
Journal
IF:
5.8
Papers:
3.4K
Citations:
9.5K

